ALKT Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Alkami Technology Inc (ALKT) is not a strong buy at the moment for a beginner investor seeking long-term growth. While the company shows strong revenue growth and positive product developments, its financials still reflect losses, and the recent analyst sentiment and price target revisions indicate caution. The technical indicators suggest the stock is nearing resistance levels, and options data shows low bullish sentiment. Therefore, it is better to hold off on investing right now and monitor for improved financial performance or stronger bullish signals.
The MACD is positive and expanding, indicating bullish momentum. However, the RSI is at 70.514, which is in the neutral zone but approaching overbought territory. The stock is currently trading near its resistance level (R1: 17.419), suggesting limited immediate upside potential. Moving averages are converging, providing no clear directional signal.
Launch of the Alkami Engage platform to enhance digital banking adoption.
Introduction of the Digital Sales & Service Platform, which reflects increased market demand post-MANTL acquisition.
Strong Q4 revenue growth of 34.73% YoY.
Analysts have lowered price targets across the board, citing SaaS multiple compression and below-consensus guidance.
Gross margin dropped by 5.38% YoY, indicating potential cost pressures.
Near-term profitability guidance is slightly light, with net income still in the negative territory.
In Q4 2025, Alkami's revenue increased by 34.73% YoY to $120.79M, and net income improved by 49.69% YoY to -$11.44M. EPS also improved by 37.50% YoY to -0.11. However, gross margin declined by 5.38% YoY to 55.78%. While revenue growth is strong, the company remains unprofitable, which could be a concern for long-term investors.
Analysts have mixed views on ALKT. While some maintain a Buy or Outperform rating, price targets have been significantly lowered across the board, ranging from $18 to $28. Analysts cite SaaS multiple compression, below-consensus guidance, and slower platform deployments as reasons for caution. However, the underlying business is considered healthy by some analysts.
